Bradykinin Receptor Antagonists

DBCAT001656Pharmacologic class

Compounds and drugs that inhibit ligand binding or cellular signaling by BRADYKININ RECEPTORS. A DrugBank category of 4 drugs. 1 of them is approved.

Also known as
Antagonists, Bradykinin · Antagonists, Bradykinin Receptor · Bradykinin Antagonists · Bradykinin Receptor Blockers · Bradykinin Receptor Inhibitors

What you can answer from here — as of May 31, 2018

4DrugsEach linked to its full drug card
Listed above
2Drug targetsEvery drug–target pair in the class, with bond type
Sign in
67Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
2Routes of administrationHow the drugs in this class are given
Sign in

Which targets do Bradykinin Receptor Antagonists share, and which companies have late-stage candidates in this class?

Create a free account or log in to explore the full data card.

Create Account